SRES. 732In Committee
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Expresses the sense of the Senate that mifepristone safety evidence should be respected and medication abortion access policies should be equitable transparent and science based
Plain-English overview
What this bill does
Expresses the sense of the Senate that mifepristone safety evidence should be respected and medication abortion access policies should be equitable transparent and science based
Key points
- Express support for mifepristone evidence
Current status
Where it stands
Status
In Committee
Latest action
2026-05-14 — Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)
Related context
Topics and policy areas
undefinedHealth
